These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6954889)

  • 1. Mechanisms of recovery of brain acetylcholinesterase in rats during chronic intoxication by isoflurophate.
    Michalek H; Meneguz A; Bisso GM
    Arch Toxicol Suppl; 1982; 5():116-9. PubMed ID: 6954889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular forms of rat brain acetylcholinesterase in DFP intoxication and subsequent recovery.
    Michalek H; Meneguz A; Bisso GM
    Neurobehav Toxicol Teratol; 1981; 3(3):303-12. PubMed ID: 7290286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development factors affecting brain acetylcholinesterase inhibition and recovery in DFP-treated rats.
    Bisso GM; Meneguz A; Michalek H
    Dev Neurosci; 1982; 5(5-6):508-19. PubMed ID: 7160316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro effects of diisopropyl fluorophosphate and paraoxon on individual molecular forms of rat brain acetylcholinesterase.
    Volpe MT; Bisso GM; Michalek H
    Neurochem Res; 1990 Oct; 15(10):975-9. PubMed ID: 2077431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of PAM, proPAM, and DFP on behavior, thermoregulation, and brain AChE in rats.
    Kenley RA; Howd RA; Uyeno ET
    Pharmacol Biochem Behav; 1982 Nov; 17(5):1001-8. PubMed ID: 7178195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acetylcholinesterase containing neurons in the rat brain after DFP-pretreatment (author's transl)].
    Pfister C; Wenk H; Danner H
    Acta Histochem; 1981; 69(2):176-86. PubMed ID: 6177182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the levels and forms of rat plasma cholinesterases during chronic diisopropylphosphorofluoridate intoxication.
    Traina ME; Serpietri LA
    Biochem Pharmacol; 1984 Feb; 33(4):645-53. PubMed ID: 6704181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of 1,2,3,4-tetrahydro-9-aminoacridine (THA) as a pretreatment drug for protection of mice from acute diisopropylfluorophosphate (DFP) intoxication.
    Galli A; Mori F
    Arch Toxicol; 1991; 65(4):330-4. PubMed ID: 1953352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo action of diisopropylfluorophosphate, of atropine and their synergism on acetylcholinesterase activity.
    Molinengo L; Ghi P
    Pharmacology; 1989; 39(3):154-9. PubMed ID: 2587621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms involved in the development of tolerance to DFP toxicity.
    Gupta RC; Patterson GT; Dettbarn WD
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S17-28. PubMed ID: 4092885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diisopropylfluorophosphate on brain acetylcholinesterase, butyrylcholinesterase, and neurotoxic esterase in rats.
    Lim DK; Hoskins B; Ho IK
    Biomed Environ Sci; 1989 Sep; 2(3):295-304. PubMed ID: 2610946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of acetylcholinesterase by meptazinol in mice exposed to di-isopropyl fluorophosphate. Comparison with physostigmine.
    Galli A; Mori F
    J Pharm Pharmacol; 1991 May; 43(5):366-9. PubMed ID: 1680183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of muscarinic receptor density and acetylcholinesterase activity in repeated DFP-treated rats after the termination of DFP administration.
    Lim DK; Hoskins B; Ho IK
    Eur J Pharmacol; 1986 Apr; 123(2):223-8. PubMed ID: 3709665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of acetylcholinesterase activity after acute organophosphate treatment of CNS reaggregate cultures.
    Wehner JM; Smolen A; Smolen TN; Murphy C
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1104-9. PubMed ID: 4092872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against diisopropylfluorophosphate intoxication by meptazinol.
    Galli A; Mazri A
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):388-96. PubMed ID: 3188007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional differences in brain-soluble acetylcholinesterase and its molecular forms after acute poisoning by isoflurophate in rats.
    Meneguz A; Bisso GM; Michalek H
    Clin Toxicol; 1981 Dec; 18(12):1443-51. PubMed ID: 7333079
    [No Abstract]   [Full Text] [Related]  

  • 17. Variation of commercial diisopropyl fluorophosphate preparations in toxicological studies.
    Ho IK; Hoskins B
    Drug Chem Toxicol; 1983; 6(5):421-7. PubMed ID: 6628264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in central and peripheral neural actions between soman and diisopropyl fluorophosphate, organophosphorus inhibitors of acetylcholinesterase.
    Misulis KE; Clinton ME; Dettbarn WD; Gupta RC
    Toxicol Appl Pharmacol; 1987 Jul; 89(3):391-8. PubMed ID: 3603567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholinesterase activity in several rat liver cell fractions after repeated poisoning with some organophosphates.
    Gajewski D
    Acta Physiol Pol; 1980; 31(5):575-80. PubMed ID: 7234437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in response of acetylcholinesterase to diisopropylfluorophosphate in the mesencephalic raphe region. A microelectrophoretic, histochemical, and biochemical study in albino rats.
    Seidel J; Scheibler P; Müller M
    Acta Histochem; 1989; 85(1):65-72. PubMed ID: 2496574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.